Stereotaxis STXS recently announced the publication of initial clinical results from its MAGiC catheter in the Journal of ...

Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of These 10 Stocks Are Making Big Moves. Viking Therapeutics jumped by 9.74 ...

BEACON and Open-Label Extension Study Design and Data Summary: ...

NMRA-861 has demonstrated a potentially best-in-class pharmacological profile and robust activity in preclinical efficacy models. NMRA-861 was safe and well-tolerated in pre-clinical toxicology ...

Researchers have provided robust scientific evidence that ailments like depression, high blood pressure, diabetes mellitus, ...

In the Phase 1 portion of the CELC-G-201 clinical trial evaluating gedatolisib plusdarolutamide in men with metastatic castration resistant prostate cancer ("mCRPC"),the six-month radiographic progres ...

The Phase III BASIS trial found that once-weekly subcutaneous Hympavzi reduced treated bleed rates by 93% in patients with ...

The clinical trial support services market is experiencing significant growth, driven by the increasing incidence of chronic illnesses such as cancer, diabetes, and cardiovascular diseases. This rise ...

Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and ...

An FDA-funded clinical trial found even modest CBD use triggered elevated liver enzymes in some healthy adults, raising safety concerns.

Investigator initiated exploratory clinical study being conducted in Israel pursuant to agreement with collaboration partner, PeriNessCompany evaluating systemic recombinant human DNase I (DNase I) in ...